DTIL - Precision BioSciences Inc logo

Precision BioSciences Inc

DTIL

Precision BioSciences develops in vivo gene editing therapies using its ARCUS platform, focusing on gene insertion, excision, and repair. Its products target conditions like chronic hepatitis B, Duchenne muscular dystrophy, and mitochondrial diseases.

โš•๏ธ Healthcare NASDAQ Listed 2019 $ USD
$1,000 invested 5 years ago โ†’$23today

Score Overview

1 Year
Score
Net Growth-15.33%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth31.49%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.4
Net Growth-72.32%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-61.00%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth43.22%
Net Trend43%
Net Income Consistency
Rev Growth102.60%
Rev Trend71%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Precision BioSciences Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. DTIL does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 6.78โ€”
1 Year2025-10-22
$ 6.93-2.16%
5 Years2021-10-22
$ 289.50-97.66%
All Time2019-03-28
$ 523.20-98.70%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 45M-$ 52M$ 87M
2025$ 34M-$ 45M$ 115M
2024$ 68M$ 7M$ 86M
2023$ 48M-$ 61M$ 116M
2022$ 25M-$ 111M$ 189M
2021$ 115M-$ 30M$ 143M
2020$ 24M-$ 109M$ 89M
IPO2019$ 22M-$ 92M$ 180M
DTIL - Precision BioSciences Inc logo

Precision BioSciences Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 24M to $ 34M and net income went from -$ 109M to -$ 45M. Revenue increased in 3 of those 5 years; net income in 2.

Precision BioSciences Inc currently holds a 5-year HDB Score of 3.4 out of 10. How the HDB Score is calculated.

Membership

Explore DTIL with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies